Amit Anand, MD

Assistant Professor, Medicine

Amit Anand
617.789.2545
72 E. Concord Street

Other Positions

  • St. Elizabeth's Medical Center

Websites

Education

  • Seth G.S. Medical College, MBBS

Publications

  • Published on 6/3/2024

    Jha MK, Wilkinson ST, Krishnan K, Collins KA, Sanacora G, Murrough J, Goes F, Altinay M, Aloysi A, Asghar-Ali A, Barnett B, Chang L, Costi S, Malone D, Nikayin S, Nissen SE, Ostroff R, Reti I, Wolski K, Wang D, Hu B, Mathew SJ, Anand A. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 03; 7(6):e2417786. PMID: 38916891.

    Read at: PubMed
  • Published on 12/1/2023

    Mathew SJ, Jha MK, Anand A. Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine? JAMA Psychiatry. 2023 Dec 01; 80(12):1187-1188. PMID: 37878334.

    Read at: PubMed
  • Published on 9/7/2023

    Anand A, Mathew SJ, Hu B. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. Reply. N Engl J Med. 2023 Sep 07; 389(10):961-962. PMID: 37672705.

    Read at: PubMed
  • Published on 5/24/2023

    Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, Aloysi AS, Asghar-Ali AA, Barnett BS, Chang LC, Collins KA, Costi S, Iqbal S, Jha MK, Krishnan K, Malone DA, Nikayin S, Nissen SE, Ostroff RB, Reti IM, Wilkinson ST, Wolski K, Hu B. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. N Engl J Med. 2023 Jun 22; 388(25):2315-2325. PMID: 37224232.

    Read at: PubMed
  • Published on 3/29/2023

    Niemsiri V, Rosenthal SB, Nievergelt CM, Maihofer AX, Marchetto MC, Santos R, Shekhtman T, Alliey-Rodriguez N, Anand A, Balaraman Y, Berrettini WH, Bertram H, Burdick KE, Calabrese JR, Calkin CV, Conroy C, Coryell WH, DeModena A, Eyler LT, Feeder S, Fisher C, Frazier N, Frye MA, Gao K, Garnham J, Gershon ES, Goes FS, Goto T, Harrington GJ, Jakobsen P, Kamali M, Kelly M, Leckband SG, Lohoff FW, McCarthy MJ, McInnis MG, Craig D, Millett CE, Mondimore F, Morken G, Nurnberger JI, Donovan CO, Øedegaard KJ, Ryan K, Schinagle M, Shilling PD, Slaney C, Stapp EK, Stautland A, Tarwater B, Zandi PP, Alda M, Fisch KM, Gage FH, Kelsoe JR. Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis. Mol Psychiatry. 2024 Jan; 29(1):6-19. PMID: 36991131.

    Read at: PubMed
  • Published on 4/4/2022

    Hu B, Cha J, Fullerton JM, Hesam-Shariati S, Nakamura K, Nurnberger JI, Anand A. Genetic and environment effects on structural neuroimaging endophenotype for bipolar disorder: a novel molecular approach. Transl Psychiatry. 2022 Apr 04; 12(1):137. PMID: 35379780.

    Read at: PubMed
  • Published on 3/14/2022

    Tamman A, Anand A, Mathew SJ. A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression. Expert Opin Drug Saf. 2022 Jun; 21(6):745-759. PMID: 35253555.

    Read at: PubMed
  • Published on 1/21/2022

    Cha J, Spielberg JM, Hu B, Altinay M, Anand A. Differences in network properties of the structural connectome in bipolar and unipolar depression. Psychiatry Res Neuroimaging. 2022 Apr; 321:111442. PMID: 35152051.

    Read at: PubMed
  • Published on 1/7/2022

    Cha J, Spielberg JM, Hu B, Altinay M, Anand A. Resting-state functional connectivity graph-properties correlate with bipolar disorder-risk in young medication-free depressed subjects: Bipolar-risk Resting State Functional Connectivity in Major Depression. J Affect Disord. 2022 Mar 15; 301:52-59. PMID: 35007643.

    Read at: PubMed
  • Published on 3/26/2021

    Taylor JJ, Kurt HG, Anand A. Resting State Functional Connectivity Biomarkers of Treatment Response in Mood Disorders: A Review. Front Psychiatry. 2021; 12:565136. PMID: 33841196.

    Read at: PubMed

View 15 more publications: View full profile at BUMC

View all profiles